I 

113TH CONGRESS 

1ST SESSION H. R. 2363 

To foster further innovation and entrepreneurship in the health information 

technology sector. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 13, 2013 

Mr. HONDA introduced the following bill; which was referred to the Committee 

on Energy and Commerce, and in addition to the Committees on Ways 

and Means and Small Business, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions 

as fall within the jurisdiction of the committee concerned 

A BILL 

To foster further innovation and entrepreneurship in the 

health information technology sector. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Health Care Innova5 tion and Marketplace Technologies Act of 2013’’. 


pwalker on DSK7TPTVN1PROD with BILLS
2 

•HR 2363 IH

1 SEC. 2. HEALTH INFORMATION TECHNOLOGY PLACED IN 

2 SERVICE BY MEDICAL CARE PROVIDER. 

3 (a) IN GENERAL.—Part VI of subchapter B of chap4 ter 1 of the Internal Revenue Code of 1986 is amended 

5 by adding at the end the following: 

6 ‘‘SEC. 200. HEALTH IT PLACED IN SERVICE BY MEDICAL 

7 CARE PROVIDER. 

8 ‘‘(a) IN GENERAL.—In the case of a medical care 

9 provider, there shall be allowed as a deduction an amount 

10 equal to the amount paid or incurred by the medical care 

11 provider for qualified health information technology placed 

12 in service by the provider during the taxable year. 

13 ‘‘(b) LIMITATION.—The amount allowed as a deduc14 tion to a medical care provider by subsection (a) for a tax15 able year shall not exceed $250,000. 

16 ‘‘(c) DEFINITIONS.—For purposes of this section— 

17 ‘‘(1) MEDICAL CARE PROVIDER.—The term 

18 ‘medical care provider’ means— 

19 ‘‘(A) a provider of services (as defined in 

20 section 1861(u) of the Social Security Act (42 

21 U.S.C. 1395x(u)), 

22 ‘‘(B) a provider of medical or health serv23 ices (as defined in section 1861(s) of the Social 

24 Security Act (42 U.S.C. 1395x(s)), and 


pwalker on DSK7TPTVN1PROD with BILLS
3 

•HR 2363 IH

1 ‘‘(C) any other person who furnishes, bills, 

2 or is paid for health care in the normal course 

3 of business. 

4 ‘‘(2) QUALIFIED HEALTH INFORMATION TECH5 NOLOGY.—The term ‘qualified health information 

6 technology’ means the application of information 

7 processing involving both computer hardware and 

8 software that deals with the storage, retrieval, shar9 ing, and use of health care information, data, and 

10 knowledge for communication and decisionmaking. 

11 Such term does not include certified EHR tech12 nology. 

13 ‘‘(d) SPECIAL RULES.— 

14 ‘‘(1) PASS-THRU ENTITIES.—In the case of a 

15 partnership or S corporation, this section shall be 

16 applied at the entity level and at the partner or simi17 lar level. 

18 ‘‘(2) COORDINATION WITH OTHER DEDUC19 TIONS.—Any amount taken into account under sub20 section (a) shall not be allowed as a deduction under 

21 any other section of this chapter. 

22 ‘‘(e) TERMINATION.—This section shall not apply to 

23 amounts paid or incurred after December 31, 2018.’’. 


pwalker on DSK7TPTVN1PROD with BILLS
4 

•HR 2363 IH

1 (b) CLERICAL AMENDMENT.—The table of sections 

2 for part VI of subchapter B of chapter 1 of such Code 

3 is amended by adding at the end the following new item: 

‘‘Sec. 200. Health IT placed in service by medical care provider.’’. 

4 (c) EFFECTIVE DATE.—The amendments made by 

5 this section shall apply to taxable years beginning after 

6 December 31, 2013. 

7 SEC. 3. SMALL BUSINESS HEALTH INFORMATION TECH8 NOLOGY FINANCING PROGRAM. 

9 The Small Business Act (15 U.S.C. 631 et seq.) is 

10 amended by redesignating sections 45, 46, and 47 as sec11 tions 46, 47, and 48, respectively, and by inserting the 

12 following new section after section 44: 

13 ‘‘SEC. 45. LOAN GUARANTEES FOR HEALTH INFORMATION 

14 TECHNOLOGY. 

15 ‘‘(a) DEFINITIONS.—As used in this section: 

16 ‘‘(1) The term ‘health information technology’ 

17 means computer hardware, software, services, and 

18 related technology that is purchased by an eligible 

19 professional to aid in the provision of health care in 

20 a health care setting and that provides for— 

21 ‘‘(A) enhancement of continuity of care for 

22 patients through electronic storage, trans23 mission, and exchange of relevant personal 

24 health data and information, such that this in25 formation is accessible at the times and places 


pwalker on DSK7TPTVN1PROD with BILLS
5 

•HR 2363 IH

1 where clinical decisions will be or are likely to 

2 be made; 

3 ‘‘(B) enhancement of communication be4 tween patients and health care providers; 

5 ‘‘(C) improvement of quality measurement 

6 by eligible professionals enabling them to col7 lect, store, measure, and report on the proc8 esses and outcomes of individual and population 

9 performance and quality of care; 

10 ‘‘(D) improvement of evidence-based deci11 sion support; 

12 ‘‘(E) enhancement of consumer and pa13 tient empowerment; or 

14 ‘‘(F) services that assist with workflow re15 design, training, system configuration, human 

16 change management and other similar services 

17 focused on getting the best value from existing 

18 technology that has already been purchased. 

19 Such term shall not include information technology 

20 whose sole use is financial management, mainte21 nance of inventory of basic supplies, or appointment 

22 scheduling. 

23 ‘‘(2) The term ‘eligible professional’ means any 

24 of the following: 


pwalker on DSK7TPTVN1PROD with BILLS
6 

•HR 2363 IH

1 ‘‘(A) A physician (as defined in section 

2 1861(r) of the Social Security Act (42 U.S.C. 

3 1395x(r))). 

4 ‘‘(B) A practitioner described in section 

5 1842(b)(18)(C) of that Act. 

6 ‘‘(C) A physical or occupational therapist 

7 or a qualified speech-language pathologist. 

8 ‘‘(D) A qualified audiologist (as defined in 

9 section 1861(ll)(3)(B)) of that Act. 

10 ‘‘(E) A State-licensed pharmacist. 

11 ‘‘(F) A State-licensed, a State-certified, or 

12 a nationally accredited home health care pro13 vider. 

14 ‘‘(3) The term ‘qualified eligible professional’ 

15 means an eligible professional whose office can be 

16 classified as a small business concern by the Admin17 istrator for purposes of this Act under size stand18 ards established under section 3 of this Act. 

19 ‘‘(b) LOAN GUARANTEES FOR QUALIFIED ELIGIBLE

20 PROFESSIONALS.— 

21 ‘‘(1) IN GENERAL.—Subject to paragraph (2), 

22 the Administrator may guarantee up to 90 percent 

23 of the amount of a loan made to a qualified eligible 

24 professional to be used for the acquisition of health 

25 information technology for use in such eligible proVerDate Mar 15 2010 03:47 Jun 20, 2013 Jkt 029200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H2363.IH H2363

pwalker on DSK7TPTVN1PROD with BILLS
7 

•HR 2363 IH

1 fessional’s medical practice and for the costs associ2 ated with the installation of such technology. Except 

3 as otherwise provided in this section, the terms and 

4 conditions that apply to loans made under section 

5 7(a) of this Act shall apply to loan guarantees made 

6 under this section. 

7 ‘‘(2) LIMITATIONS ON GUARANTEE AMOUNTS.— 

8 The maximum amount of loan principal guaranteed 

9 under this subsection may not exceed— 

10 ‘‘(A) $250,000 with respect to any single 

11 qualified eligible professional; and 

12 ‘‘(B) $500,000 with respect to a single 

13 group of affiliated qualified eligible profes14 sionals. 

15 ‘‘(c) FEES.—(1) The Administrator may impose a 

16 guarantee fee on the borrower for the purpose of reducing 

17 the cost (as defined in section 502(5) of the Federal Credit 

18 Reform Act of 1990) of the guarantee to zero in an 

19 amount not to exceed 2 percent of the total guaranteed 

20 portion of any loan guaranteed under this section. The Ad21 ministrator may also impose annual servicing fees on lend22 ers not to exceed 0.5 percent of the outstanding balance 

23 of the guarantees on lenders’ books. 

24 ‘‘(2) No service fees, processing fees, origina25 tion fees, application fees, points, brokerage fees, 


pwalker on DSK7TPTVN1PROD with BILLS
8 

•HR 2363 IH

1 bonus points, or other fees may be charged to a loan 

2 applicant or recipient by a lender in the case of a 

3 loan guaranteed under this section. 

4 ‘‘(d) DEFERRAL PERIOD.—Loans guaranteed under 

5 this section shall carry a deferral period of not less than 

6 1 year and not more than 3 years. The Administrator shall 

7 have the authority to subsidize interest during the deferral 

8 period. 

9 ‘‘(e) EFFECTIVE DATE.—No loan may be guaranteed 

10 under this section after the date that is 6 months after 

11 the date of enactment of this section. 

12 ‘‘(f) SUNSET.—No loan may be guaranteed under 

13 this section after the date that is 10 years after the date 

14 that is 6 months after the date of enactment of this sec15 tion. 

16 ‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There 

17 are authorized to be appropriated such sums as are nec18 essary for the cost (as defined in section 502(5) of the 

19 Federal Credit Reform Act of 1990) of guaranteeing 

20 $25,000,000 in loans under this section. The Adminis21 trator shall determine such program cost separately and 

22 distinctly from other programs operated by the Adminis23 trator.’’. 


pwalker on DSK7TPTVN1PROD with BILLS
9 

•HR 2363 IH

1 SEC. 4. CHALLENGE GRANT PROGRAM; DISRUPTIVE TECH2 NOLOGIES PRIZE PROGRAM. 

3 (a) IN GENERAL.—Subtitle B of title XXX of the 

4 Public Health Service Act (42 U.S.C. 300jj–31 et. seq.) 

5 is amended— 

6 (1) by redesignating sections 3017 and 3018 as 

7 sections 3019 and 3020, respectively; and 

8 (2) by inserting after section 3016 the following 

9 new sections: 

10 ‘‘SEC. 3017. CHALLENGE GRANT PROGRAM. 

11 ‘‘(a) IN GENERAL.—Subject to the availability of ap12 propriations, the Secretary, acting through the National 

13 Coordinator, shall award competitive grants to eligible en14 tities to carry out the activities described in subsection (d). 

15 ‘‘(b) ELIGIBLE ENTITY DEFINED.—In this section, 

16 the term ‘eligible entity’ means any individual or entity, 

17 except for an entity that— 

18 ‘‘(1) has 500 or more employees; and 

19 ‘‘(2) has an annual revenue of $7,000,000 or 

20 more. 

21 ‘‘(c) APPLICATION.—An eligible entity seeking a 

22 grant under this section shall submit an application to the 

23 National Coordinator at such time, in such manner, and 

24 containing such information as the National Coordinator 

25 may require, including a description of the product, procVerDate Mar 15 2010 03:47 Jun 20, 2013 Jkt 029200 PO 00000 Frm 00009 Fmt 6652 Sfmt 6201 E:\BILLS\H2363.IH H2363

pwalker on DSK7TPTVN1PROD with BILLS
10 

•HR 2363 IH

1 ess, or structure described in subsection (d) for which the 

2 entity intends to use the grant. 

3 ‘‘(d) USES OF FUNDS.—An eligible entity that re4 ceives a grant under this section shall use such funds to 

5 develop an effective product, process, or structure that en6 hances the use, particularly by patients, of health informa7 tion technology, by— 

8 ‘‘(1) integrating more than one aspect of health 

9 information; 

10 ‘‘(2) performing a medical consultation using 

11 technology; 

12 ‘‘(3) providing health information to physicians 

13 or patients; 

14 ‘‘(4) allowing better coordination during the de15 livery and follow-up after the delivery of health care; 

16 or 

17 ‘‘(5) addressing any of the three areas that the 

18 Commission established under section 3018(e)(1) 

19 has identified pursuant to its duties under section 

20 3018(e)(2)(A). 

21 ‘‘(e) PROHIBITED USE OF FUNDS.—An eligible entity 

22 that receives a grant under this section may not use such 

23 grant to develop a product, process, or structure that 

24 meets only the requirements that are necessary to be a 

25 certified EHR technology. 


pwalker on DSK7TPTVN1PROD with BILLS
11 

•HR 2363 IH

1 ‘‘(f) GRANT AMOUNT.—A grant awarded under this 

2 section may not be greater than $75,000. 

3 ‘‘(g) REPORT.—Not later than one year after the 

4 date of receipt of a grant under this section, an eligible 

5 entity shall submit to the National Coordinator and the 

6 Administrator of the Centers for Medicare & Medicaid 

7 Services a report that describes— 

8 ‘‘(1) the progress that the entity has made on 

9 the product, process, or structure funded by the 

10 grant; and 

11 ‘‘(2) how patients, health care providers, and 

12 other individuals and entities involved in the delivery 

13 of healthcare, including the Centers for Medicare & 

14 Medicaid Services, could use the product, process, or 

15 structure funded by the grant to enhance the deliv16 ery of and reduce the cost of health care. 

17 ‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 

18 is authorized to be appropriated to carry out this section 

19 $5,000,000 for each of fiscal years 2015 through 2017. 

20 ‘‘SEC. 3018. DISRUPTIVE TECHNOLOGIES PRIZE PROGRAM. 

21 ‘‘(a) PRIZE PROGRAM AUTHORIZED.—For purposes 

22 of rewarding innovation in health information technology, 

23 the Secretary, acting through the National Coordinator, 

24 shall carry out a program to award one prize competitively 

25 in each of the three areas identified by the Commission 


pwalker on DSK7TPTVN1PROD with BILLS
12 

•HR 2363 IH

1 under subsection (e)(2)(A) using the benchmarks devel2 oped under subsection (e)(2)(B) to select the prize recipi3 ent in each category. 

4 ‘‘(b) ADMINISTRATION OF PROGRAM.—In carrying 

5 out the program under subsection (a), the following shall 

6 apply: 

7 ‘‘(1) ADVERTISING.—The National Coordinator 

8 shall widely advertise the prize competition to en9 courage broad participation. 

10 ‘‘(2) REQUIREMENTS AND REGISTRATION.—The 

11 National Coordinator shall publish a notice in the 

12 Federal Register announcing— 

13 ‘‘(A) the rules for being eligible to partici14 pate in the competition; 

15 ‘‘(B) the process for participants to reg16 ister for the competition; 

17 ‘‘(C) the areas of health information tech18 nology that the Commission develops under 

19 subsection (e)(2)(A) for each prize; and 

20 ‘‘(D) the benchmarks that the Commission 

21 develops under subsection (e)(2)(B) based on 

22 which a winner will be selected in each such 

23 area. 

24 ‘‘(c) ELIGIBILITY.—To be eligible to win a prize 

25 under this section, an individual or entity— 


pwalker on DSK7TPTVN1PROD with BILLS
13 

•HR 2363 IH

1 ‘‘(1) shall register to participate in the competi2 tion in accordance with any rules promulgated by 

3 the National Coordinator under subsection (b)(2); 

4 ‘‘(2) in the case of an entity, shall be incor5 porated in and maintain a primary place of business 

6 in the United States, and in the case of an indi7 vidual, whether participating singly or in a group, 

8 shall be a citizen or permanent resident of the 

9 United States; and 

10 ‘‘(3) may not be a Federal entity or Federal 

11 employee acting within the scope of their employ12 ment; and 

13 ‘‘(4) shall submit an application that includes 

14 an explanation of the anticipated market viability of 

15 the technology that such individual or entity would 

16 develop with funds received under the prize program. 

17 ‘‘(d) PRIZE AMOUNT.— 

18 ‘‘(1) IN GENERAL.—Subject to paragraph (2), a 

19 prize awarded under this section shall be in the 

20 amount of $10,000,000. 

21 ‘‘(2) ALTERNATIVE RULE.—In the case that the 

22 amount made available for prize awards under this 

23 section is less than $33,000,000, the National Coor24 dinator may reserve not more than 10 percent for 

25 the administrative costs of carrying out this section, 


pwalker on DSK7TPTVN1PROD with BILLS
14 

•HR 2363 IH

1 and shall divide the remaining amount equally for 

2 the three prizes awarded under this section. 

3 ‘‘(e) COMMISSION.— 

4 ‘‘(1) IN GENERAL.—There is established a com5 mission to carry out the activities described in para6 graph (2) (referred to in this section as the ‘Com7 mission’). 

8 ‘‘(2) DUTIES.— 

9 ‘‘(A) AREAS OF HEALTH INFORMATION

10 TECHNOLOGY.—For the purposes of the prize 

11 program under subsection (a), the Commission 

12 shall identify three areas within the field of 

13 health information technology that are not ade14 quately addressed by certified EHR tech15 nologies and the use of such technologies. Each 

16 area identified shall be an area that will pro17 mote the development of technologies that 

18 would be widely useful, would help decrease the 

19 cost of health care, and would improve the qual20 ity of health care, particularly for patients. 

21 ‘‘(B) BENCHMARKS.—The Commission 

22 shall develop the benchmarks that the National 

23 Coordinator shall use to determine the prize re24 cipient in each area identified under subparaVerDate Mar 15 2010 03:47 Jun 20, 2013 Jkt 029200 PO 00000 Frm 00014 Fmt 6652 Sfmt 6201 E:\BILLS\H2363.IH H2363

pwalker on DSK7TPTVN1PROD with BILLS
15 

•HR 2363 IH

1 graph (A). The Commission shall identify such 

2 benchmarks with the goals of— 

3 ‘‘(i) attracting participants from out4 side the health information technology field 

5 that will take new approaches to address6 ing the areas identified by the Commission 

7 under subparagraph (A); 

8 ‘‘(ii) solving such challenges; and 

9 ‘‘(iii) promoting the development of 

10 technologies that will be widely adopted, 

11 particularly by patients. 

12 ‘‘(C) RESTRICTION OF PRIZE AWARD.— 

13 The Commission shall determine how to restrict 

14 the prize recipients’ use of the funds awarded 

15 as a prize under this section, with respect to 

16 the development of health information tech17 nology, in order to ensure that the prize recipi18 ents use such funds to further develop the tech19 nologies for which such prize was awarded. 

20 ‘‘(3) MEMBERS.— 

21 ‘‘(A) NUMBER AND APPOINTMENT.—The 

22 Commission shall be composed of 10 members 

23 appointed by the National Coordinator not later 

24 than 90 days after the date of the enactment of 

25 this Act. 


pwalker on DSK7TPTVN1PROD with BILLS
16 

•HR 2363 IH

1 ‘‘(B) COMPOSITION.—Each member of the 

2 Commission shall be appointed to represent one 

3 of the following four categories: 

4 ‘‘(i) The varied disciplines within the 

5 health information technology field. 

6 ‘‘(ii) The varied disciplines within the 

7 medical field that are not described in 

8 clause (i). 

9 ‘‘(iii) Individuals who— 

10 ‘‘(I) represent a patient-led, pa11 tient-centered organization with a pa12 tient constituency; 

13 ‘‘(II) have experience with health 

14 information technology and privacy; 

15 and 

16 ‘‘(III) are trained, knowledgeable, 

17 and prepared to participate in the de18 cisionmaking process regarding health 

19 information technology. 

20 ‘‘(iv) Officers or employees of the 

21 Federal Government. 

22 ‘‘(C) REPRESENTATION OF MEMBERSHIP

23 CATEGORIES.—At least two members of the 

24 Commission shall represent each of the cat25 egories described in subparagraph (B). 


pwalker on DSK7TPTVN1PROD with BILLS
17 

•HR 2363 IH

1 ‘‘(D) TRAVEL EXPENSES.—Each member 

2 shall receive travel expenses, including per diem 

3 in lieu of subsistence, in accordance with appli4 cable provisions under subchapter I of chapter 

5 57 of title 5, United States Code. 

6 ‘‘(E) FIRST MEETING.—The Commission 

7 shall hold its first meeting not later than 180 

8 days after the date of the enactment of this 

9 Act. 

10 ‘‘(4) REPORT TO THE NATIONAL COORDI11 NATOR.—Not later than one year after the date of 

12 enactment of this Act, the Commission shall submit 

13 to the National Coordinator a report containing the 

14 areas, benchmarks, and restrictions on the uses of 

15 prize awards that the Commission identifies for the 

16 prize program under paragraph (2). 

17 ‘‘(5) TERMINATION.—The Commission shall 

18 terminate upon submitting its report to the National 

19 Coordinator under paragraph (4). 

20 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—In addi21 tion to sums authorized to be appropriated to carry out 

22 this subtitle under section 3020, there is authorized to be 

23 appropriated to carry out this section $33,000,000 for fis24 cal year 2015.’’. 

25 (b) CONFORMING AMENDMENTS.— 


pwalker on DSK7TPTVN1PROD with BILLS
18 

•HR 2363 IH

1 (1) Section 3011 of such Act (42 U.S.C. 300jj– 

2 31) is amended— 

3 (A) in subsection (a), by striking ‘‘section 

4 3018’’ and inserting ‘‘section 3020’’; and 

5 (B) in subsection (c), by striking ‘‘section 

6 3018’’ and inserting ‘‘section 3020’’. 

7 (2) Section 3020 of such Act (as so redesig8 nated) is amended by inserting ‘‘except for section 

9 3018,’’ after ‘‘For purposes of carrying out this sub10 title,’’. 

11 SEC. 5. ESTABLISHMENT OF THE OFFICE OF WIRELESS 

12 HEALTH TECHNOLOGY. 

13 Chapter X of the Federal Food, Drug, and Cosmetic 

14 Act (21 U.S.C. 391 et seq.) is amended by adding at the 

15 end the following new section: 

16 ‘‘SEC. 1013. OFFICE OF WIRELESS HEALTH TECHNOLOGY. 

17 ‘‘(a) ESTABLISHMENT.—There is established within 

18 the Office of the Commissioner an office to be known as 

19 the Office of Wireless Health Technology (referred to in 

20 this section as the ‘Office’), which shall be headed by a 

21 director. 

22 ‘‘(b) APPOINTMENT OF FIRST DIRECTOR.—The first 

23 Director of the Office shall be appointed by the Commis24 sioner not later than 90 days after the date of enactment 

25 of this section. 


pwalker on DSK7TPTVN1PROD with BILLS
19 

•HR 2363 IH

1 ‘‘(c) DUTIES.—The Director of the Office shall— 

2 ‘‘(1) through public meetings and other forms 

3 of communication with individuals and entities that 

4 design, produce, disseminate, or have a prevailing in5 terest in wireless health technology, receive and ana6 lyze recommendations with respect to ways that ex7 isting regulations regarding wireless health tech8 nology might be made more reasonable and predict9 able, including ways that such regulations could be 

10 clarified and simplified; 

11 ‘‘(2) coordinate with Federal agencies, offices, 

12 institutes, and centers involved in the regulation of 

13 wireless health technology, including the Federal 

14 Communications Commission, the Office of the Na15 tional Coordinator for Health Information Tech16 nology, the Centers for Medicare & Medicaid Serv17 ices, the Agency for Healthcare Research and Qual18 ity, the National Institute of Standards and Tech19 nology, the Health Resources and Services Adminis20 tration, and the National Institutes of Health, re21 garding activities of such agencies, offices, institutes, 

22 and centers that can be improved so as to make 

23 such regulation more robust, predictable, and easily 

24 understood and navigated by individuals and entities 


pwalker on DSK7TPTVN1PROD with BILLS
20 

•HR 2363 IH

1 that design, produce, disseminate, or have a pre2 vailing interest in wireless health technology; 

3 ‘‘(3) provide information to individuals and en4 tities that design, produce, disseminate, or have a 

5 prevailing interest in wireless health technology on 

6 how to design, produce, or disseminate wireless 

7 health technology in accordance with existing law; 

8 and 

9 ‘‘(4) publish and make available on the public 

10 Internet Web site of the Food and Drug Administra11 tion in a searchable format an annual report that— 

12 ‘‘(A) explains how the Food and Drug Ad13 ministration implemented regulations regarding 

14 wireless health technology during the prior 

15 year; 

16 ‘‘(B) analyzes the effectiveness of— 

17 ‘‘(i) such regulations; and 

18 ‘‘(ii) other wireless health-related ef19 forts by the Food and Drug Administra20 tion; and 

21 ‘‘(C) provides specific recommendations on 

22 how the Food and Drug Administration should 

23 improve its practices with regard to wireless 

24 health technology (in a manner that ensures 

25 consistency within the Food and Drug AdminisVerDate Mar 15 2010 03:47 Jun 20, 2013 Jkt 029200 PO 00000 Frm 00020 Fmt 6652 Sfmt 6201 E:\BILLS\H2363.IH H2363

pwalker on DSK7TPTVN1PROD with BILLS
21 

•HR 2363 IH

1 tration regarding the application of its regu2 latory approach without compromising patient 

3 safety or privacy) in order to— 

4 ‘‘(i) remove barriers to innovations in 

5 such technology; and 

6 ‘‘(ii) align such practices with the 

7 practices of other Federal agencies. 

8 ‘‘(d) CONSULTATION WITH WORKING GROUPS AND

9 COMMISSIONS.—In carrying out the duties specified in 

10 subsection (c), the Director of the Office may consult with 

11 any working groups or commissions, including any work12 ing group or commission convened for a purpose related 

13 to the regulation of wireless health technology. 

14 ‘‘(e) DEFINITION OF WIRELESS HEALTH TECH15 NOLOGY.—For purposes of this section, the term ‘wireless 

16 health technology’ has such meaning as specified by the 

17 Commissioner pursuant to regulation, but in no case shall 

18 include technology this is not regulated under the provi19 sions of this Act (other than this section). 

20 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 

21 is authorized to be appropriated to carry out this section 

22 $1,000,000 for each of fiscal years 2015 through 2019.’’. 


pwalker on DSK7TPTVN1PROD with BILLS
22 

•HR 2363 IH

1 SEC. 6. MOBILE HEALTH SOFTWARE APPLICATION TECH2 NOLOGY RESPONSIBILITIES OF THE HEALTH 

3 INFORMATION TECHNOLOGY RESEARCH 

4 CENTER. 

5 Section 3012 of the Public Health Service Act (42 

6 U.S.C. 300jj–32) is amended— 

7 (1) in subsection (b), by adding at the end the 

8 following new paragraph: 

9 ‘‘(4) ENCOURAGEMENT OF DESIGN, PRODUC10 TION, AND DISSEMINATION OF MOBILE HEALTH

11 SOFTWARE APPLICATION TECHNOLOGY.— 

12 ‘‘(A) IN GENERAL.—In addition to the 

13 purposes under paragraph (3), the Center 

14 shall— 

15 ‘‘(i) establish an educational Web site 

16 repository and a response mechanism (such 

17 as a national telephone number) to provide 

18 timely responses to questions in order to 

19 make information available and provide di20 rect support to individuals and entities 

21 that design, produce, disseminate, or have 

22 a prevailing interest in mobile health soft23 ware application technology regarding the 

24 actions such individuals and entities must 

25 take in order to ensure that such techVerDate Mar 15 2010 03:47 Jun 20, 2013 Jkt 029200 PO 00000 Frm 00022 Fmt 6652 Sfmt 6201 E:\BILLS\H2363.IH H2363

pwalker on DSK7TPTVN1PROD with BILLS
23 

•HR 2363 IH

1 nology is designed, produced, and dissemi2 nated in accordance with Federal law; and 

3 ‘‘(ii) publish and make available on 

4 the public Internet Web site of the Depart5 ment in a searchable format an annual re6 port that— 

7 ‘‘(I) highlights and explains the 

8 laws and regulations that commonly 

9 impede efforts by individuals and enti10 ties to design, produce, or disseminate 

11 mobile health software application 

12 technology; and 

13 ‘‘(II) discusses the work the Cen14 ter has completed in the past year 

15 with regard to mobile health software 

16 application technology, including ac17 complishments by the Center and 

18 challenges that may require more 

19 work or outside support in order for 

20 the Center to accomplish the objec21 tives outlined in this subparagraph. 

22 ‘‘(B) DEFINITION OF MOBILE HEALTH

23 SOFTWARE APPLICATION TECHNOLOGY.—For 

24 purposes of subparagraph (A), the term ‘mobile 


pwalker on DSK7TPTVN1PROD with BILLS
24 

•HR 2363 IH

1 health software application technology’ means a 

2 software program that— 

3 ‘‘(i) offers health-related services and 

4 runs on a mobile device; or 

5 ‘‘(ii) enables health-related services 

6 through other portals associated with the 

7 use of a mobile device. 

8 ‘‘(C) AUTHORIZATION OF APPROPRIA9 TIONS.—There is authorized to be appropriated 

10 to carry out this paragraph $500,000 for each 

11 of fiscal years 2015 through 2019.’’; and 

12 (2) in subsection (c)(8), by deleting ‘‘paragraph 

13 (3)’’ and inserting ‘‘paragraphs (3) and (4)’’. 

14 SEC. 7. WORKFORCE RETRAINING GRANTS. 

15 (a) IN GENERAL.—The National Coordinator for 

16 Health Information Technology may award to eligible en17 tities grants to be used for training health care workers 

18 in health information technology (in this section referred 

19 to as ‘‘HIT’’). 

20 (b) PERIOD OF GRANT.—The period of a grant under 

21 this section shall be 24 months. 

22 (c) ELIGIBLE ENTITIES.—In this section, ‘‘eligible 

23 entities’’ means entities that provide clinical health care 

24 services to individuals within the United States. 


pwalker on DSK7TPTVN1PROD with BILLS
25 

•HR 2363 IH

1 (d) JOB TRANSITION.—As a condition on receipt of 

2 a grant under this section, a grantee shall ensure that 

3 each employee whose HIT training is funded by that grant 

4 assumes expanded duties with the grantee, either in the 

5 form of a new employment position or revised duties with6 in such employee’s existing employment position, that re7 quires the use of HIT, not more than 1 year after the 

8 employee completes the training. 

9 (e) REPORTING.—Each grantee shall submit a report 

10 not later than 24 months after receipt of a grant to the 

11 National Coordinator for Health Information Technology 

12 including the following: 

13 (1) The number of employees who received 

14 training pursuant to the grant. 

15 (2) The HIT skills covered during such training 

16 or trainings. 

17 (3) Documentation that each trained employee 

18 commenced or will commence work in a new position 

19 that satisfies the condition set forth in subsection 

20 (d). 

21 (f) AUTHORIZATION OF APPROPRIATIONS.—There 

22 are authorized to be appropriated to carry out this section 

23 $10,000,000 for each of fiscal years 2015 through 2019. 

Æ 


pwalker on DSK7TPTVN1PROD with BILLS